Radiotherapy After Prostatectomy Increased PFS in pT3 Prostate Cancer
Saturday, May 23rd, 2009 Posted in prostate related, radiation therapy | No Comments »According to data from a randomized trial, radiotherapy given after radical prostatectomy increased biochemical PFS by 18% after five years among men with pT3 disease. These results support data from two previously published studies: the EORTC trial 229111 and a ...
Results of phase I trial of novel herbal therapy for men at high risk of prostate cancer
Saturday, May 23rd, 2009 Posted in alternative treatments | No Comments »Results of a phase I clinical trial of a novel herb-based therapeutic called Zyflamend have demonstrated that the therapy is associated with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer. The new findings, led ...
Genetic marker may help clinicians distinguish between men who are at risk for earlier onset of prostate cancer
Friday, May 22nd, 2009 Posted in prostate cancer diagnosis | No Comments »"Genetic testing for prostate cancer is not yet clinically well characterized as it is for breast, ovarian cancer and colon cancer," says Veda Giri, M.D., a medical oncologist and director of the Prostate Cancer Risk Assessment Program at Fox Chase. Recently, ...
Advanced Prostate Cancer Deadlier in Younger Men
Friday, May 22nd, 2009 Posted in prostate cancer | No Comments »A new study finds.that young men with prostate cancer do quite well, although the young men that have more advanced prostate cancers did substantially worse than old men with similar forms of the disease. According to study conclusion, among men with ...
Gleason score 4+3 associated with greater prostate cancer risk
Thursday, May 21st, 2009 Posted in prostate cancer risks | No Comments »The Gleason scoring system is an important method of classifying prostate cancers based on the appearance of the prostate cancer cells under a microscope. Gleason patterns range from one to five, with higher Gleason patterns being associated with more aggressive disease. ...
Long-term study shows low oxygen levels in prostate tumors can predict recurrence
Thursday, May 21st, 2009 Posted in prostate cancer | No Comments »Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer. The long-term study results will be presented at ...
Prtostate cancer diagnosis treatment may be improved by a protein that suppresses androgen receptors
Wednesday, May 20th, 2009 Posted in prostate cancer, prostate cancer diagnosis | No Comments »Researchers from Medical College of Georgia report in Proceedings of the National Academy of Sciences Online Early Edition this week that a protein that helps regulate expression of androgen receptors could prove a new focal point for staging and treating ...
Rapid test for prostate cancer
Tuesday, May 19th, 2009 Posted in prostate cancer diagnosis | No Comments »A mixed team representing researchers from Durham University's Chemistry Department qnd experts from the University of Maryland, USA, have developed the test by using light energy to measure the level of citrate in fluid samples from the prostate gland. The ...
Aid to Customize Aggressive Prostate Cancer Treatment
Monday, May 18th, 2009 Posted in prostate cancer | No Comments »Researchers claim to have found a way to better customize the treatment of prostate cancer. Four risk factors that can help predict how long men could survive with metastatic prostate cancer have been identified by researchers from the Duke Comprehensive Cancer ...
How long should you stay on hormones when you get radiotherapy?
Monday, May 18th, 2009 Posted in radiation therapy | No Comments »There is now a considerable amount of data available in more “modern” patients suggesting that short periods of neoadjuvant and adjuvant therapy are sufficient to control locally advanced prostate cancer in combination with the higher doses of radiation that are ...